Truist Financial
CRDF icon

Truist Financial’s Cardiff Oncology CRDF Stock Holding History

Truist Financial’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-127,985
Closed -$769K – 2703
2021
Q4 		$769K Sell
127,985
-32,415
-20% -$193K ﹤0.01% 1785
2021
Q3 		$1.07M Sell
160,400
-92
-0.1% -$578 ﹤0.01% 1559
2021
Q2 		$1.07M Buy
160,492
+41,092
+34% +$349K ﹤0.01% 1611
2021
Q1 		$1.11M Buy
119,400
+4,400
+4% +$53.5K ﹤0.01% 1532
2020
Q4 		$2.07M Buy
+115,000
New +$2.02M ﹤0.01% 1158

Other funds holding CRDF

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Truist Financial's CRDF Position: Q1 2022 in Review

Truist Financial sold out of Cardiff Oncology (CRDF) in Q1 2022, closing a stake of 127,985 shares — an estimated $769K sold.

Truist Financial first reported a position in CRDF in Q4 2020 and held it in 5 quarters. The position peaked at $2.07M in Q4 2020. 91 funds tracked by Wall St. Rank hold CRDF as of Q1 2022.

  • Truist Financial reported no remaining Cardiff Oncology position as of Q1 2022 after selling out during the quarter.
  • Truist Financial sold 127,985 Cardiff Oncology shares in Q1 2022, an estimated $769K.
  • Truist Financial first reported a position in Cardiff Oncology in Q4 2020 and held it in 5 quarters.
  • Truist Financial's Cardiff Oncology position peaked at $2.07M in Q4 2020.
  • 91 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2022.

Based on Truist Financial's 13F filing for Q1 2022, filed 22 Apr 2022.